Page last updated: 2024-09-02

sri 63-441 and Pregnancy

sri 63-441 has been researched along with Pregnancy in 3 studies

*Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. [MeSH]

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
O'Neill, C	1
O'Neill, C; Ryan, JP; Spinks, NR	1
O'Neill, C; Spinks, NR	1

Other Studies

3 other study(ies) available for sri 63-441 and Pregnancy

Article	Year
Platelet-activating factor-antagonists reduce implantation in mice at low doses only. Reproduction, fertility, and development, 1995, Volume: 7, Issue:1 Topics: Animals; Azepines; Diterpenes; Dose-Response Relationship, Drug; Embryo Implantation; Female; Ginkgolides; Injections, Intraperitoneal; Lactones; Mice; Platelet Aggregation Inhibitors; Pregnancy; Quinolinium Compounds; Time Factors; Triazoles	1995
Antagonists of embryo-derived platelet-activating factor act by inhibiting the ability of the mouse embryo to implant. Journal of reproduction and fertility, 1990, Volume: 88, Issue:1 Topics: Animals; Azepines; Blastocyst; Decidua; Embryo Implantation; Embryo Transfer; Epoprostenol; Female; Iloprost; Mice; Mice, Inbred Strains; Platelet Activating Factor; Pregnancy; Quinolinium Compounds; Triazines; Triazoles; Trophoblasts	1990
Embryo-deprived platelet-activating factor is essential for establishment of pregnancy in the mouse. Lancet (London, England), 1987, Jan-10, Volume: 1, Issue:8524 Topics: Animals; Embryo Implantation; Embryo, Mammalian; Epoprostenol; Female; Humans; Iloprost; Mice; Platelet Activating Factor; Pregnancy; Pregnancy, Animal; Quinolinium Compounds; Time Factors	1987